Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).

Similar documents
MRC-Holland MLPA. Description version 08; 30 March 2015

SALSA MLPA probemix P169-C2 HIRSCHSPRUNG-1 Lot C As compared to version C1 (lot C1-0612), the length of one probe has been adjusted.

MRC-Holland MLPA. Description version 14; 28 September 2016

MRC-Holland MLPA. Description version 12; 13 January 2017

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

MRC-Holland MLPA. Description version 30; 06 June 2017

MRC-Holland MLPA. Description version 29; 31 July 2015

MRC-Holland MLPA. Description version 07; 26 November 2015

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D2-0716, D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

MRC-Holland MLPA. Description version 18; 09 September 2015

SALSA MLPA probemix P315-B1 EGFR

MRC-Holland MLPA. Description version 08; 18 November 2016

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B

P323-B1 CDK4-HMGA2-MDM2

MRC-Holland MLPA. Description version 08; 07 May 2015

MRC-Holland MLPA. Description version 06; 23 December 2016

SALSA MLPA probemix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four probes have been adjusted.

New: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix.

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509

MRC-Holland MLPA. Description version 06; 07 August 2015

MRC-Holland MLPA. Description version 19;

SALSA MLPA KIT P050-B2 CAH

SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A

MRC-Holland MLPA. Related SALSA MLPA probemixes P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, PTEN, TP53.

MRC-Holland MLPA. Description version 29;

SALSA MLPA KIT P060-B2 SMA

MRC-Holland MLPA. Description version 52; 22 July 2015

MRC-Holland MLPA. Description version 13;

PRADER WILLI/ANGELMAN

SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407

SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109

SALSA MLPA probemix P383-A1 T-ALL Lot A

SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B and B

MRC-Holland MLPA. Description version 23; 15 February 2018

Product Description SALSA MS-MLPA Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol.

SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length.

MRC-Holland MLPA. Description version 05; 03 April 2019

MRC-Holland MLPA. Description version 28; 4 January 2018

Product Description SALSA MLPA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P055-D1 PAH To be used with the MLPA General Protocol.

MRC-Holland MLPA. Description version 23; 26 January 2017

MRC-Holland MLPA. Description version 10; 06 April 2018

Product Description SALSA MLPA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

MRC-Holland MLPA. Description version 15;

Product Description SALSA MLPA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol.

SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced.

Product Description SALSA MLPA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Clinical evaluation of microarray data

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

CHROMOSOMAL MICROARRAY (CGH+SNP)

Product Description SALSA MLPA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

Sharan Goobie, MD, MSc, FRCPC

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Certificate of Analysis

What s the Human Genome Project Got to Do with Developmental Disabilities?

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol.

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Product Description SALSA MLPA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Updating penetrance estimates for syndromes with variable phenotypic manifestation. Adele Corrigan June 27th

MRC-Holland MLPA. Description version 24;

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD

MLPA SAMPLES USER GUIDE

An Unexpected Function of the Prader-Willi Syndrome Imprinting Center in Maternal Imprinting in Mice

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

Case 1B. 46,XY,-14,+t(14;21)

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our

5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits?

22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona)

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017

MLPA analysis in a cohort of patients with autism

New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads

Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs

Epigenetics and Chromatin Remodeling

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology

Detection of copy number variations in PCR-enriched targeted sequencing data

The Human Major Histocompatibility Complex

Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University

Product Description SALSA MLPA Probemix P250-B2 DiGeorge To be used with the MLPA General Protocol.

SEAMLESS CGH DIAGNOSTIC TESTING

Genetic Testing for the Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters

Section: Medicine Effective Date: January15, 2016 Subsection: Pathology/Laboratory Original Policy Date: December 7, 2011 Subject:

Peeling the Onion. Layers of the ASD Onion. A History of Autism. Understanding the Neurobiology of Autism Spectrum Disorders! Thursday May 8, 2014

UNIQUE DELETIONS IN PRADER-WILLI SYNDROME

The Evolving Role of MeCP2 in Rett Syndrome and Autism

Corporate Medical Policy

THE PENNSYLVANIA STATE UNIVERSITY SCHREYER HONORS COLLEGE DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

Genetics and Genomics: Applications to Developmental Disability

MODULE NO.14: Y-Chromosome Testing

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

Genetics update and implications for (General) Practice

Clinical Interpretation of Cancer Genomes

MEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG)

November 9, Johns Hopkins School of Medicine, Baltimore, MD,

Transcription:

SALSA MLPA probemix P343-C3 Autism-1 Lot C3-1016. As compared to version C2 (lot C2-0312) five reference probes have been replaced, one reference probe added and several lengths have been adjusted. Warning: All SHANK3 probes are located in an extremely CG-rich chromosomal area. Such CpG islands are more difficult to denature than the rest of the human genome. The presence of salt in DNA samples can result in incomplete denaturation of these CpG islands, which may result in false positive results: apparent deletions of several consecutive SHANK3 probes, while reference probes are normal. Such false positive results are even more likely when DNA has been extracted by the Qiagen EZ1, M48 or M96 system, as these leave a higher salt concentration in the sample. High salt concentrations can also be due to evaporation (dried out samples; SpeedVac concentration). Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment). Multiple studies postulate that at least some autism cases have a genetic basis and many different loci have been implicated in autism. This P343-C3 probemix contains MLPA probes for three of these chromosomal regions: the 15q11-q13 (including UBE3A, GABRB3 and the 15q13 microdeletion region with CHRNA7), the 16p11 microdeletion region and the SHANK3 gene at 22q13. Within the 15q11 region, two probes have been included for the SNRPN-HB2-85 cluster, five for the UBE3A gene, two for ATP10A, seven for GABRB3 and two for OCA2. The great majority of these probes differ from the probes present in the ME028 Prader-Willi-Angelman probemix. This P343 probemix may therefore also be useful for further characterisation of large deletions in Prader-Willi-Angelman patients. In addition, nine probes are present detecting 15q13 sequences, including three probes that are located within the common 15q13 microdeletion region described by Sharp A.J. et al (Nature Genetics 2008, 40:322-328). The 16p11.2 region is covered by 11 probes detecting sequences in the 28.9-30.2 Mb region. Genomic imbalances of an approximately 600 kb region in 16p11.2 (29.5-30.1 Mb) have been associated with autism, intellectual disability, congenital anomalies, and schizophrenia. Please note that 15q11, 15q13 and 16p11.2 deletions and duplications have also been described in healthy individuals. Phenotype prediction for abnormalities detected in these regions is very difficult. The SHANK3 gene (22 exons) spans ~58 kb of genomic DNA and is located on 22q13.33, 49 Mb from the p-telomere. Three probes are included for SHANK3 gene (exons 3, 14, and 21). Finally, ten reference probes are included in this probemix, detecting different autosomal chromosomal locations. This SALSA probemix is designed to detect/duplications of one or more sequences in the above mentioned chromosomal regions in a DNA sample. Heterozygous deletions of recognition sequences should give a 35-50% reduced relative peak height of the amplification product of that probe. Note that a mutation or polymorphism in the sequence detected by a probe can also cause a reduction in relative peak height, even when not located exactly on the ligation site! In addition, some probe signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by MLPA should always be confirmed by other methods. Not all deletions and duplications detected by MLPA will be pathogenic; users should always verify the latest scientific literature when interpreting their findings. Finally, note that most defects in these regions are expected to be small (point) mutations which will not be detected by this SALSA test. SALSA probemixes and reagents are sold by for research purposes and to demonstrate the possibilities of the MLPA technique. They are not CE/FDA certified for use in diagnostic procedures. Purchase of the SALSA test probemixes and reagents includes a limited license to use these products for research purposes. The use of a SALSA probemix and reagents requires a thermocycler with heated lid and sequence type electrophoresis equipment. Different fluorescent PCR primers are available. The MLPA technique has been first described in Nucleic Acid Research 30, e57 (2002). SALSA probemix P343 Autism-1 Page 1 of 7

Related SALSA probemixes ME028 PWS/AS: Contains probes to detect Prader-Willi and Angelman syndrome (15q region). P188 22q13: Broad screening of the 22q13 region. P325 OCA2: Contains probes for nearly all OCA2 exons. P336 UBE3A: Contains probes for all UBE3A exons. P339 SHANK3: Contains probes for all SHANK3 exons. P396 SHANK2: Contains probes for all SHANK2 exons. References Moreira, DP et al., 2014. Investigation of 15q11-q13, 16p11.2 and 22q13 CNVs in autism spectrum disorder Brazilian individuals with and without epilepsy. PloS one, 9(9), e107705. Rodriguez-Lopez, J et al., 2015. An efficient screening method for simultaneous detection of recurrent copy number variants associated with psychiatric disorders. Clinica Chimica Acta, 445, 34-40. Moreira, ES et al., 2016. Detection of small copy number variations (CNVs) in autism spectrum disorder (ASD) by custom array comparative genomic hybridization (acgh). Res Autism Spectr Disord, 23, 145-151. SzczaĂ, K et al., 2016. Paternally Inherited GABRB3 Intragenic Deletion in a Boy with Autistic Features and Angelman Syndrome Phenotype Case Report and Literature Review. Autism-Open Access, 1-4. More information Website : www.mlpa.com E-mail : info@mlpa.com (information & technical questions); order@mlpa.com (for orders) Mail : bv; Willem Schoutenstraat 1, 1057 DL Amsterdam, the Netherlands Data analysis The P343-C3 Autism probemix contains 50 MLPA probes with amplification products between 121 and 500 nt. In addition, it contains 9 control fragments generating an amplification product smaller than 120 nt: four DNA Quantity fragments (Q-fragments) at 64-70-76-82 nt, three DNA Denaturation control fragments (Dfragments) at 88-92-96 nt, one X-fragment at 100 nt and one Y-fragment at 105 nt. More information on how to interpret observations on these control fragments can be found in the MLPA protocol. Data generated by this probemix can first be normalised intra-sample by dividing the peak height of each probe s amplification product by the total peak height of only the reference probes in this probemix (block normalisation). Secondly, inter-sample normalisation can be achieved by dividing this intra-normalised probe ratio in a sample by the average intra-normalised probe ratio of all reference samples. Please note that this type of normalisation assumes that no changes occurred in the genomic regions recognised by the reference probes. Data normalisation should be performed within one experiment. Only samples purified by the same method should be compared. Confirmation of most exon deletions and amplifications can be done by e.g. Southern blotting, long range PCR, qpcr, FISH. Note that Coffalyser, the MLPA analysis tool developed at, can be downloaded free of charge from our website www.mlpa.com. Many copy number alterations in healthy individuals are described in the database of genomic variants: http://dgv.tcag.ca/dgv/app/home. For example, a duplication of a complete gene might not be pathogenic, while a partial duplication or a deletion may result in disease. For some genes, certain in-frame deletions may result in a very mild, or no disease. Copy number changes of reference probes are unlikely to be the cause of the condition tested for. Users should always verify the latest scientific literature when interpreting their findings. This probemix was developed at. Info/remarks/suggestions for improvement: info@mlpa.com. SALSA probemix P343 Autism-1 Page 2 of 7

Table 1. SALSA MLPA P343-C3 Autism-1 probemix Length Chromosomal position SALSA MLPA probe (nt) reference 15q11-q13 / Exon 16p11 SHANK3 64-70-76-82 Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA 88-92-96 D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation 100 X-fragment: Specific for the X chromosome 105 Y-fragment: Specific for the Y chromosome 121 * Reference probe 19616-L27455 4p13 130 * Reference probe 08640-L08656 3q26 136 ATP10A probe 12964-L14669 15q12 Exon 1 142 UBE3A probe 10883-L11553 15q11 Exon 5 148 GABRB3 probe 10872-L11542 15q12 Exon 6 154 Reference probe 09431-L09680 11q13 160 UBE3A probe 04620-L14668 15q11 Exon 3 166 KLF13 probe 08376-L08230 15q13 Exon 2 172 HIRIP3 probe 11667-L14670 Exon 3 178 NDNL2 probe 08377-L08231 15q13 Exon 1 184 GABRB3 probe 10868-L11538 15q12 Exon 4 190 * Reference probe 20256-L23585 12q12 197 UBE3A probe 10880-L11550 15q11 Exon 2 202 APBA2 probe 01314-L00867 15q13 Exon 14 208 SEZ6L2 probe 11668-L12439 Exon 1 214 SNRPN-HB2-85 probe 21014-L29483 15q11 220 GABRB3 probe 01315-L09339 15q12 Exon 9 226 DOC2A probe 13162-L12447 Exon 4 232 «SHANK3 probe 06787-L07383 Exon 21 238 «MAZ probe 11669-L12440 Exon 5 244 UBE3A probe 10886-L14677 15q11 Exon 8 250 Reference probe 02658-L02125 11q22 256 UBE3A probe 01317-L12925 15q11 Exon 9 264 * Reference probe 08874-L19215 1p31 270 ATP10A probe 11165-L12883 15q12 Exon 16 286 CHRNA7 probe 12956-L08237 15q13 Exon 4 292 GABRB3 probe 10875-L11545 15q12 Exon 8 300 «TJP1 probe 08389-L14671 15q13 Intron 1 310 «SHANK3 probe 20567-L14007 Exon 3 319 GABRB3 probe 10870-L11540 15q12 Exon 5 328 * Reference probe 07631-L07316 10q26 337 CD2BP2 probe 11671-L12442 Exon 4 346 MVP probe 00550-L22423 Exon 5 355 GABRB3 probe 10867-L11537 15q12 Exon 3 364 SPN probe 11672-L12443 Exon 3 373 TRPM1 probe 08397-L14672 15q13 Exon 27 382 GABRB3 probe 10874-L11544 15q12 Exon 7 391 «SHANK3 probe 14190-L15800 Exon 14 400 * Reference probe 15766-L24901 14q32 409 Reference probe 07208-L06858 7p14 420 «MAZ probe 11673-L29557 Exon 6 427 SCG5 probe 12951-L29660 15q13 Exon 6 436 OCA2 probe 02040-L01553 15q12-13 Exon 22 445 OCA2 probe 02041-L03725 15q12-13 Exon 1 454 HIRIP3 probe 11674-L12445 Exon 4 465 MAPK3 probe 11675-L12446 Exon 5 475 SNRPN-HB2-85 probe 12720-L13795 15q11 483 LAT probe 11677-L12448 Exon 4 492 SCG5 probe 12954-L14464 15q13 Exon 3 500 Reference probe 10218-L14675 7q22 * New in version C3 (from lot C3-1016 onwards). Changed in version C3 (from lot C3-1016 onwards). Small change in length, no change in sequence detected. «This probe is located within, or close to, a very strong CpG island. A low signal of this probe can be due to incomplete sample DNA denaturation, e.g. due to the presence of salt in the sample DNA. SALSA probemix P343 Autism-1 Page 3 of 7

Note: Exon numbering used here may differ from literature! Please notify us of any mistakes. The identity of the genes detected by the reference probes is available on request: info@mlpa.com. Table 2. P343-C3 probes arranged according to chromosomal location Table 2a. 15q11-15q13 area Length SALSA MLPA Ligation site Partial sequence (24 nt Distance to Gene Exon (nt) probe NM_sequence adjacent to ligation site) next probe 214 21014-L29483 SNRPN-HB2-85 AAGAAATCCCTT-CCAGGAGGGCTC 10.2 kb 475 12720-L13795 SNRPN-HB2-85 AAGTTCTTTAAC-GTCATCGGCTTG 277.9 kb UBE3A gene (NM_130838.1) stop codon 2601-2603 (ex10) 256 01317-L12925 UBE3A Exon 9(13) 2368-2369 TCATTCATTTAC-AGATGAACAGAA 14.2 kb 244 10886-L14677 UBE3A Exon 8(12) 2336-2337 TCTGTTCTGATT-AGGTGAGGTACT 2.4 kb 142 10883-L11553 UBE3A Exon 5(9) 1896-1897 TCTACAGGAAGC-TAATGGGGAAAA 14.8 kb 160 04620-L14668 UBE3A Exon 3(7) 614-615 TCTTCCTCAAGG-ATAGGTGATAGC 4.2 kb 197 10880-L11550 UBE3A Exon 2(6) 94-95 CTACCACCAGTT-AACTGAGGGCTG 312.1 kb start codon 45-47 (ex1) ATP10A gene (NM_024490.3) stop codon 4604-4606 (ex21) 270 11165-L12883 ATP10A Exon 16 3303-3304 TGCAGTGCCGAA-ATTCCGATACCT 175.0 kb 136 12964-L14669 ATP10A Exon 1 375-376 GGCCAACGTGTA-CTTTGTCTTCAT 685.2 kb start codon 107-109 (ex1) GABRB3 gene (NM_021912.4) stop codon 1484-1486 (ex9) 220 01315-L09339 GABRB3 Exon 9(12) 1233-1234 CGATACCAGGAA-TTCAGCAATATC 13.1 kb 292 10875-L11545 GABRB3 Exon 8(11) 10 nt before exon 8(11) CACCACTTTGTT-TCTTTTCTAGGG 6.5 kb 382 10874-L11544 GABRB3 Exon 7(10) 796-797 AGGAACATTGGA-TACTTCATTCTT 12.6 kb 148 10872-L11542 GABRB3 Exon 6(9) 18 nt after exon 6(9) CCTGCATCCACT-TATAGTCCCTTC 3.1 kb 319 10870-L11540 GABRB3 Exon 5(8) 29 nt before exon 5(8) CAGCCCTTCTTT-AATATCTTCCCT 38.0 kb 184 10868-L11538 GABRB3 Exon 4(7) 376-377 GGGATCCCTCTC-AACCTCACGCTT 151.0 kb 355 10867-L11537 GABRB3 Exon 3(4) 248-249 GTCCCCCGGTCT-GCGTGGGGATGA 1201.5 kb start codon 65-67 (ex1) OCA2 gene (NM_000275.2) stop codon 2625-2627 (ex24) 436 02040-L01553 OCA2 Exon 22 2420-2421 CCGCTCATGTAT-GCCCTGGCCTTC 247.8 kb 445 02041-L03725 OCA2 Exon 1 88-87 reverse TGCACTTTACCT-GCGCACTTGCAG 1178.8 kb start codon 111-113 (ex2) 202 01314-L00867 APBA2 CACCACCCACTT-GATTTTTTTCAT 152.0 kb 178 08377-L08231 NDNL2 CTCTTGGGTTCA-AGTTCCACCAGC 552.2 kb 300 «08389-L14671 TJP1 CACAGGCTGAGT-GGAGTGTTTTGC 1180.5 kb 373 08397-L14672 TRPM1 ATGGACATCCTA-GGAATGTGAAAT 370.6 kb 166 08376-L08230 KLF13 TTGAACCCCCTT-TCTCAGGGATGG 739.3 kb 286 12956-L08237 CHRNA7 AGACTGTTCGTT-TCCCAGATGGCC 568.0 kb 492 12954-L14464 SCG5 Exon 3 NM_003020.3; 421-422 TGACTGGAGACA-ACATTCCTAAGG 16.8 kb 427 12951-L29660 SCG5 Exon 6 NM_003020.3; 806-807 TCAGCATGGCTT-ATGTGCACGTGT The TRPM1, KLF13 and CHRNA7 probes are located within the common 15q13 microdeletion region that has been described by Sharp A.J. et al (Nature Genetics 2008 40:322-328). Please note that Helbig identified 15q13 duplications not only in 12 out of 1223 epilepsy patients but also in 23 out of 3699 control samples. 15q13 deletions were identified in 12 out of 1223 individuals with idiopathic generalized epilepsy by Helbig et al (Nature Genetics 2009 41:160-162) and in 9 out of 3391 schizophrenia patients (Nature 2008 455: 237-241). No 15q13 deletions were detected in 3181 control samples. SALSA probemix P343 Autism-1 Page 4 of 7

The NM_130838.1 sequence represents transcript variant 1. The NM_024490.3 sequence is a reference standard in the NCBI RefSeqGene project. The NM_021912.4 sequence represents transcript variant 2 and is a reference standard in the NCBI RefSeqGene project. The NM_000275.2 sequence represents transcript variant 1 and is a reference standard in the NCBI RefSeqGene project. Table 2b. 16p11 area Length (nt) SALSA MLPA probe Gene detected Partial sequence (24 nt adjacent to ligation site) Mapview 36 location (hg18) Distance to next probe p-telomere 483 11677-L12448 LAT ACCAGTTTGTAT-CCAAGGGGCATC 28.904647 678.2 kb 364 11672-L12443 SPN CCATCAAGATGT-CATCAGTGCCCC 29.582828 145.5 kb 238 «11669-L12440 MAZ CCACGGCAGCAT-ACCTGCGCATCC 29.728356 0.8 kb 420 «11673-L29557 MAZ GAAGAAATGTTT-TCTTAGGGGAAT 29.729166 23.6 kb 346 00550-L22423 MVP GTCGTGGAGATC-ATTCAGGCCACC 29.752775 65.1 kb 208 11668-L12439 SEZ6L2 GCAGCCAGATTA-CTTAGAGAGGCA 29.817845 95.7 kb 454 11674-L12445 HIRIP3 GGCGAGCCTCAA-AGGCAGTTGAGG 29.913518 0.5 kb 172 11667-L14670 HIRIP3 CCAGGGAAGACA-AACTGGACCTTA 29.913975 14.0 kb 226 13162-L12447 DOC2A CACTTGCTGCCT-GGAGCCTGTAAG 29.928004 108.5 kb 465 11675-L12446 MAPK3 CTGGATCAGCTC-AACCACATTCTG 30.036474 236.3 kb 337 11671-L12442 CD2BP2 GGAAGGCCACTT-TGATGCCGATGG 30.272761 centromere A recurrent microdeletion syndrome on 16p11.2-p12.2 has been described by Ballif BC et al (2007, Nature Genetics 39:1071-1073). Phenotype included developmental delay. Size of the deletion is different in the five subjects described, however all included the PALB2 and IL21R genes. Table 2c. SHANK3 gene Length (nt) SALSA MLPA probe SHANK3 Exon Ligation site NM_033517.1 Partial sequence (24 nt adjacent to ligation site) Distance to next probe start codon 1-3 (ex 1) 310 «20567-L14007 Exon 3 288-289 AAGCGGCGAGTT-TATGCCCAGAAC 27.6 kb 391 «14190-L15800 Exon 14(15) 1749-1750 GAGGGCTTTGGT-TTTGTGCTCCGG 18.1 kb 232 «06787-L07383 Exon 21(22) 4481-4482 ACCAACTGTGAT-CAGTGAGCTCAG stop codon 5194-5196 (ex 22) The SHANK3 gene is complicated and many SHANK3 probes have a higher than average standard deviation in many of our tests. Apparent deletions and duplications observed by only one or two of these probes should be treated with caution. All SHANK3 probes are located in an extremely GC rich chromosomal area. Such CpG islands are more difficult to denature than the rest of the human genome. The presence of salt in DNA samples can result in incomplete denaturation of these CpG islands, and may result in false positive results (apparent deletions of several consecutive SHANK3 probes, while the reference probes are normal). Such false positive results can in particular be obtained when DNA is purified by the Qiagen EZ1, M48 and M96 systems. High salt concentrations can also be due to evaporation (dried out samples; SpeedVac concentration). The NM_033517.1 sequence is a reference standard in the NCBI RefSeqGene project. Changed in version C3 (from lot C3-1016 onwards). Small change in length, no change in sequence detected. «This probe is located within, or close to, a very strong CpG island. A low signal of this probe can be due to incomplete sample DNA denaturation, e.g. due to the presence of salt in the sample DNA. Notes The UBE3A, GABRB3 and SHANK3 exon numbering has changed. From description version 9 onwards, we have adopted the NCBI exon numbering that is present in the NM_ sequences for these genes. This exon numbering used here may differ from literature! The exon numbering used in previous versions of this product description can be found between brackets in Table 2. SALSA probemix P343 Autism-1 Page 5 of 7

The identity of the genes detected by the reference probes is available on request: info@mlpa.com. SALSA MLPA probemix P343-C3 Autism-1 sample picture Figure 1. Capillary electrophoresis pattern of a sample of approximately 50 ng human male control DNA analysed with SALSA MLPA probemix P343-C3 AUTISM-1 (lot C3-1016). Implemented Changes compared to the previous product description versions. Version 09 4 November 2016 (55) - Product description adapted to a new lot (lot number added, small changes in Table 1 and Table 2, new picture included). - New references added on page 1. - Exon numbering of the UBE3A GABRB3 and SHANK3 genes have been changed on page 3 and 4. - Small changes of probe lengths in Table 1 and 2 in order to better reflect the true lengths of the amplification products. Version 08 (48) - Figure(s) based on the use of old MLPA buffer (replaced in December 2012) removed. Version 07 (48) - Textual change below Table 2. Version 06 (48) - Electropherogram pictures using the new MLPA buffer (introduced in December 2012) added. Version 05 (48) - Product description adapted to a new lot (lot number added, small changes in Table 1 and Table 2, new picture included). Version 04 (48) - Exon numbering of the GABRB3 gene has been changed on page 3 and 4. - Remark on RefSeqGene standard added below Table 2. - Small changes of probe lengths in Table 1 and 2 in order to better reflect the true lengths of the amplification products. - Small correction of chromosomal locations in Table 1 and 2. - Various minor textual and layout changes. Version 03 (46) - Product description adapted to a new lot (lot number added, small changes in Table 1 and Table 2, new picture included). - Small changes of probe lengths in Table 1 and 2 in order to better reflect the true lengths of the amplification products. - Warning added on page 1. and below Table 2c that the SHANK3 probes are sensitive to high salt concentrations. - New related probemixes added on page 1. SALSA probemix P343 Autism-1 Page 6 of 7

- Warning added about salt-sensitive reference probe (124 nt). SALSA probemix P343 Autism-1 Page 7 of 7